Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. - O'Shea, Leah K.; Abdulkhalek, Samar; Allison, Stephanie; Neufeld, Ronald J.; Szewczuk, Myron R. (OncoTargets & Therapy, 2014)